Advertisement

 

 

Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.

Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.
Author Information (click to view)

Zhou T, Hu M, Pearlman A, Rohan LC,


Zhou T, Hu M, Pearlman A, Rohan LC, (click to view)

Zhou T, Hu M, Pearlman A, Rohan LC,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Biochemical pharmacology 2016 07 21116() 162-75 doi 10.1016/j.bcp.2016.07.009

Abstract

P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and multidrug resistance protein 4 (MRP4) are three efflux transporters that play key roles in the pharmacokinetics of antiretroviral drugs used in the pre-exposure prophylaxis of HIV sexual transmission. In this study, we investigated the expression, regulation, and function of these transporters in cervicovaginal tissues of a mouse model. Expression and regulation were examined using real-time RT-PCR and immunohistochemical staining, in the mouse tissues harvested at estrus and diestrus stages under natural cycling or after hormone synchronization. The three transporters were expressed at moderate to high levels compared to the liver. Transporter proteins were localized in various cell types in different tissue segments. Estrous cycle and exogenous hormone treatment affected transporter mRNA and protein expression, in a tissue- and transporter-dependent manner. Depo-Provera-synchronized mice were dosed vaginally or intraperitoneally with (3)H-TFV, with or without MK571 co-administration, to delineate the function of cervicovaginal Mrp4. Co-administration of MK571 significantly increased the concentration of vaginally-administered TFV in endocervix and vagina. MK571 increased the concentration of intraperitoneally-administered TFV in the cervicovaginal lavage and vagina by several fold. Overall, P-gp, Bcrp, and Mrp4 were positively expressed in mouse cervicovaginal tissues, and their expression can be regulated by the estrous cycle or by exogenous hormones. In this model, the Mrp4 transporter impacted TFV distribution in cervicovaginal tissues.

Submit a Comment

Your email address will not be published. Required fields are marked *

one × five =

[ HIDE/SHOW ]